Bioguidage search of active compounds fromWaltheria indicaL. (Malvaceae) used for asthma and inflammation treatment in Burkina Faso

    loading  Checking for direct PDF access through Ovid

Abstract

Waltheria indica is used in traditional pharmacopeia in Burkina Faso for the treatment of asthma and conditions of inflammation. To evaluate its pharmacological properties and isolate the active compounds, a study through a bioguided phytochemical approach was conducted. This search was guided by a two-level investigation. First, we evaluated the impact of various fractions on the activity of enzymes involved in smooth muscle contraction (PDE4A1α) and inflammatory processes (PLA2, 5-LOX). Second, we investigated the inhibitory effect of fractions on isolated rat trachea. The initial hydroalcoholic extract from roots of W. indica (HA), n-hexane fraction (F1), dichloromethane fraction (F2), ethyl acetate fraction (F3), residuary fraction (F4) reduced enzyme activity of PDE4A1α (inhibition of 22–42% at 50 μg/mL), 5-LOX (60–80% at 10 μg/mL), and PLA2 (42–94% at 100 μg/mL). On isolated rat trachea, only HA, F3, and fractions obtained from F3 by chromatography on silica gel column, using dichloromethane/methanol, dose dependently inhibited contraction induced by acetylcholine. IC50 was 1051 μg/mL for HA and comprised between 181 and 477 μg/mL for F3 and its fractions. The most active fractions were purified and led to the identification of (-)-epicatechin. (-)-epicatechin from W. indica dose dependently inhibited PLA2 (IC50 = 154.7 μm) and 5-LOX (IC50 = 15.8 μm). In conclusion, both inhibition of PDE4A1α, 5-LOX, and PLA2 activities and rat trachea relaxation by W. indica validate its use in traditional management of asthma and other conditions of inflammation. These effects should be, at least in part, attributed to the presence of (-)-epicatechin in roots of W. indica.

Related Topics

    loading  Loading Related Articles